Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[F-18] FDDNP-PET Clinical Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected Chronic Traumatic Encephalopathy and Alzheimer's Disease

NCT04311281 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04311281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04311281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[F-18] FDDNP-PET Clinical Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected Chronic Traumatic Encephalopathy and Alzheimer's Disease
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Withdrawn
Start date
May 31, 2021
Completion date
May 3, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

suspected alzheimer's disease (ad), suspected chronic traumatic encephalopathy (cte) or traumatic encephalopathy syndrome (tes)